Implementing a Home Blood Pressure Monitoring Program in Primary Care

Launched by COLUMBIA UNIVERSITY · May 23, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how to improve the management of high blood pressure, also known as hypertension, by encouraging patients to monitor their blood pressure at home. The researchers want to see if a special approach can help more people start using a home blood pressure monitoring program. They will look at how effective this program is when it is used in various healthcare practices that serve a wide range of patients.

If you or a loved one has been diagnosed with high blood pressure and is between the ages of 18 and 85, you might be eligible to participate. To join, participants should have seen their primary care doctor in the last six months and must not have certain serious health conditions like advanced dementia or end-stage kidney disease. Those who take part can expect to receive support for monitoring their blood pressure from home, which can help them better manage their condition. This trial is currently recruiting participants, so it’s a great opportunity to contribute to important research that could help many people with hypertension.

Gender

ALL

Eligibility criteria

• • Patient-level
• Inclusion Criteria:
• • Hypertension (as per International Statistical Classification of Diseases and Related Health Problems (ICD)-10 codes)
• • At least one completed primary care office visit during relevant 6-month pre implementation or post-implementation study time period
• • Age 18-85 years old
• Exclusion Criteria:
• • Advanced dementia or other measure of frailty (as per ICD-10 codes)
• • Pregnancy during measurement period (as per ICD-10 codes)
• • Stage 5 or end-stage kidney disease (as per ICD-10 codes)
• • Terminal illness/in hospice care (as per ICD-10 codes)
• • Practice-level
• Inclusion Criteria:
• • Primary care practice that provides care to adult patients affiliated with New York Presbyterian's Ambulatory Care Network, ColumbiaDoctors, or Weill Cornell Medicine, including practices that specialize in HIV medicine
• Exclusion Criteria:
• • Medical director declines participation in the trial
• • Site for pilot testing the supported HBPM program or its implementation strategy